Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance

Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance

Direct acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment, but drug resistance could undermine proposed global elimination targets. Real‐world studies are needed to inform the impact of widespread DAA treatment on antiviral resistance in the community. The prevalence and...

Full description

Bibliographic Details
Main Authors:	Mark W. Douglas, Enoch S.E. Tay, Dao Sen Wang, Adrian T.L. Ong, Caroline Wilson, Amy Phu, Jen Kok, Dominic E. Dwyer, Rowena A. Bull, Andrew R. Lloyd, Tanya L. Applegate, Gregory J. Dore, Anita Y. Howe, Richard Harrigan, Jacob George
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2020-06-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1496

Similar Items

An Amplicon-Based Approach for the Whole-Genome Sequencing of Human Metapneumovirus
by: Rachel L. Tulloch, et al.
Published: (2021-03-01)

Protective effect of interferon-based antiviral therapy on risk of bipolar disorder in patients with hepatitis C Virus infection: A nationwide longitudinal study
by: Mu- Hong Chen, et al.
Published: (2022-01-01)

Antiviral mechanisms of small molecules targeting the endoplasmic reticulum and Golgi apparatus
by: Howe, JD
Published: (2014)

Sequencing of the Hepatitis C Virus: A Systematic Review.
by: Brendan Jacka, et al.
Published: (2013-01-01)

The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort
by: Cenk Babayigit, et al.
Published: (2022-08-01)

Development and Validation of an In-House Real-Time Reverse-Transcriptase Polymerase Chain Reaction Assay for SARS-CoV-2 Omicron Lineage Subtyping between BA.1 and BA.2
by: David Pham, et al.
Published: (2022-08-01)

Broad-Spectrum Antivirals and Antiviral Drug Combinations
by: Valentyn Oksenych, et al.
Published: (2022-02-01)

Antiviral research : strategies in antiviral drug discovery /
by: LaFemina, Robert L., et al.
Published: (c200)

Biosurfactant potential and antiviral activity of multistrain probiotics
by: Tjie Kok, et al.
Published: (2024-01-01)

Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease — a nationwide cohort study
by: Ming-Shyan Lin, et al.
Published: (2017-08-01)

The Nationwide Landscape of K–12 School Websites in the United States
by: Royce Kimmons, et al.
Published: (2019-03-01)

Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants
by: Lok Bahadur Shrestha, et al.
Published: (2021-09-01)

Antiviral therapy of coronavirus disease 2019 (COVID-19)
by: Pao-Yu Chen, et al.
Published: (2024-01-01)

Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
by: Matthew Zirui Tay, et al.
Published: (2019-02-01)

Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: a nationwide cohort study.
by: Yi-Chun Yeh, et al.
Published: (2014-01-01)

Antiviral Defense in Invertebrates
by: Michelle L. Flenniken
Published: (2018-07-01)

P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia
by: B. Hajarizadeh, et al.
Published: (2017-08-01)

Protective mechanisms of nonneutralizing antiviral antibodies.
by: Tawny L Chandler, et al.
Published: (2023-10-01)

Protective mechanisms of nonneutralizing antiviral antibodies
by: Tawny L. Chandler, et al.
Published: (2023-10-01)

Antiviral anticoagulation
by: Edward L. G. Pryzdial, et al.
Published: (2020-07-01)

Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity
by: Nicholas A. Brasher, et al.
Published: (2021-05-01)

Neuropsychiatric disorders in chronic hepatitis C patients after receiving interferon or direct-acting antivirals: a nationwide cohort study
by: Yu Fang, et al.
Published: (2023-07-01)

Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct‐acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort
by: Sofia R. Bartlett, et al.
Published: (2022-09-01)

Evaluation of Hepatitis C Virus Core Antigen Assay in a Resource-Limited Setting in Pakistan
by: Adeel Abid, et al.
Published: (2021-07-01)

Drug Interactions in Lenacapavir-Based Long-Acting Antiviral Combinations
by: Maria E. Cilento, et al.
Published: (2022-05-01)

Artificial intelligence predicts direct-acting antivirals failure among hepatitis C virus patients: A nationwide hepatitis C virus registry program
by: Ming-Ying Lu, et al.
Published: (2024-01-01)

Broad-Spectrum Antiviral Therapeutics
by: Rider, Todd H., et al.
Published: (2011)

Broad-spectrum antiviral therapeutics.
by: Todd H Rider, et al.
Published: (2011-01-01)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
by: Abdulaziz L, et al.
Published: (2022-03-01)

Arthropod-Borne Flaviviruses in Pregnancy
by: Annaleise R. Howard-Jones, et al.
Published: (2023-02-01)

P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015
by: S.R. Bartlett, et al.
Published: (2017-08-01)

Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
by: Auda A. Eltahla, et al.
Published: (2015-09-01)

Genistein Targets STING-Driven Antiviral Responses
by: Tomalika R. Ullah, et al.
Published: (2022-08-01)

Broad-spectrum antiviral agents
by: Jun-Da eZhu, et al.
Published: (2015-05-01)

Evolution of Human Respiratory Syncytial Virus (RSV) over Multiple Seasons in New South Wales, Australia
by: Francesca Di Giallonardo, et al.
Published: (2018-09-01)

The Molecular Epidemiology and Clinical Phylogenetics of Rhinoviruses Among Paediatric Cases in Sydney, Australia
by: Dillon Charles Adam, et al.
Published: (2021-09-01)

Exploring the Potential of Iminosugars as Antivirals for Crimean-Congo Haemorrhagic Fever Virus, Using the Surrogate Hazara Virus: Liquid-Chromatography-Based Mapping of Viral N-Glycosylation and In Vitro Antiviral Assays
by: Beatrice E. Tyrrell, et al.
Published: (2023-03-01)

Antiviral therapy and prophylaxis of acute respiratory infections
by: L. V. Osidak, et al.
Published: (2016-04-01)

Origin and evolution of the zinc finger antiviral protein.
by: Daniel Gonçalves-Carneiro, et al.
Published: (2021-04-01)

Advances in Antiviral Delivery Systems and Chitosan-Based Polymeric and Nanoparticulate Antivirals and Antiviral Carriers
by: Dominika Žigrayová, et al.
Published: (2023-02-01)